Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

A vertigo relief app is in development to help adults with BPPV perform repositioning maneuvers at home. It offers guided instructions, symptom logging, and is targeted for consumer and clinical use. Validation efforts are underway through landing pages and clinician outreach.

A new vertigo relief app is in development to support adults suffering from recurrent BPPV, providing guided repositioning maneuvers, symptom tracking, and clinician integration. The app aims to address long-standing challenges in home management of vertigo, with testing and validation efforts currently underway. For example, the unbundling of the budget app demonstrates how specialized apps can absorb broader functionalities.

The proposed mobile application targets adults, particularly women and older individuals, experiencing recurrent BPPV, the most common vestibular disorder. It is designed to guide users through proven repositioning maneuvers like the Epley and Brandt-Daroff, using animated step-by-step instructions, audio cues, and gyroscope-based head-angle feedback. The app also logs dizziness episodes, triggers, and severity over time to help patients and clinicians monitor progress.

Developers plan to initially test the app through a lightweight landing page and a guest app with day-of seating lookup and schedule, measuring user engagement and completion rates. They also aim to validate market demand by pitching the app to 10-15 ENT, audiology, and vestibular physiotherapy clinics, seeking trial partnerships for between-visit patient care. The app will feature a freemium model for consumers, with basic maneuver guides free and advanced tracking, reminders, and history export available via subscription. A B2B licensing option for clinics is also planned.

Reimbursement for digital therapeutics and the rise of telehealth during COVID-19 have created a favorable environment for such solutions. Learn more about Fomo’s funding success in the digital health space. The digital vestibular rehabilitation market was estimated near USD 498 million in 2024, with a projected annual growth rate of approximately 13.5% through 2033, indicating increasing acceptance among healthcare providers and payers.

Potential Impact on Vertigo Self-Management

This app could significantly improve the quality of life for adults with BPPV by enabling effective self-treatment at home, reducing the need for long waits for specialist care, and improving episode management. For clinics, it offers a scalable way to support patient recovery and monitor symptoms remotely, potentially reducing recurrence rates and healthcare costs. The integration of motion sensors and digital tracking also advances telehealth capabilities in vestibular care.

Growing Demand for Digital Vestibular Therapies

Benign paroxysmal positional vertigo (BPPV) affects a large portion of the adult population, especially women and older adults. Traditional treatment involves in-clinic repositioning maneuvers, but access can be limited by wait times and patient difficulty performing maneuvers correctly. The COVID-19 pandemic accelerated the adoption of telehealth and home-based rehab solutions, creating opportunities for digital therapeutics in vestibular care. The market for these platforms reached an estimated USD 498 million in 2024, with a strong growth trajectory expected to continue.

Previous efforts to develop self-management tools have faced challenges due to lack of real-time guidance and symptom tracking. This new app aims to bridge that gap with motion sensing and guided instructions, aligning with broader trends toward remote healthcare and digital health adoption.

“The app’s use of gyroscope sensors and animated guidance could help patients perform maneuvers more accurately at home, reducing relapse rates.”

— an anonymous researcher

Uncertainties Around Clinical Validation and Adoption

It is not yet clear how effectively the app will perform in real-world settings or how quickly clinics and patients will adopt it. Validation through clinical trials or user studies is still pending, and regulatory or reimbursement pathways are not fully established.

Upcoming Validation and Pilot Testing Phases

The development team plans to launch a landing page and a guided Epley maneuver demo to gauge initial user interest and engagement. Concurrently, they will seek partnerships with ENT and vestibular clinics to trial the app with patients, aiming to refine features based on feedback. Results from these efforts will inform further development, regulatory considerations, and commercialization strategies.

Key Questions

How does the app guide users through vertigo treatment?

The app provides animated step-by-step instructions, audio cues, and real-time head-angle feedback using gyroscope sensors to help users perform repositioning maneuvers accurately.

Can this app replace seeing a healthcare professional?

No, the app is intended as a self-management tool and includes disclaimers emphasizing it is not a substitute for professional medical advice. Users should consult a clinician if symptoms worsen or red-flag signs appear.

Will clinics be able to recommend or license the app?

Yes, the developers plan to offer a licensing model for ENT, audiology, and physiotherapy practices, allowing them to incorporate the app into their patient care programs.

When will the app be available to the public?

The app is currently in development with pilot testing planned; a public release date has not yet been announced.

What features will the paid subscription include?

Paid plans will offer advanced symptom tracking, history export, reminders, and personalized coaching features for ongoing management.

Source: IdeaNavigator AI